
Shares of some U.S. drugmakers fall between 0.5% and 3.5% after U.S. President Donald Trump speaks on reciprocal tariffs
In extended trading, Johnson & Johnson JNJ.N down 0.6%, Moderna MRNA.O down 3.5%, Eli Lilly LLY.N down 2.4%, Bristol Myers Squibb BMY.N down 0.7% and Regeneron down 2%
The SPDR S&P Biotech ETF falls 4%
Tariffs on major drug trading partners includes 20% on the EU, 26% on India and 34% on China